Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/12289
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLeechaisit R.
dc.contributor.authorPingaew R.
dc.contributor.authorPrachayasittikul V.
dc.contributor.authorWorachartcheewan A.
dc.contributor.authorPrachayasittikul S.
dc.contributor.authorRuchirawat S.
dc.contributor.authorPrachayasittikul V.
dc.date.accessioned2021-04-05T03:02:35Z-
dc.date.available2021-04-05T03:02:35Z-
dc.date.issued2019
dc.identifier.issn9680896
dc.identifier.other2-s2.0-85070395327
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/12289-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85070395327&doi=10.1016%2fj.bmc.2019.08.001&partnerID=40&md5=6bf733408e7c36b895365a553545d17e
dc.description.abstractA library of bis-sulfonamides (9–26) were synthesized and tested for their aromatase inhibitory activities. Interestingly, all bis-sulfonamide derivatives inhibited the aromatase with IC50 range of 0.05–11.6 μM except for compound 23. The analogs 15 and 16 bearing hydrophobic chloro and bromo groups exhibited the potent aromatase inhibitory activity in sub-micromolar IC50 values (i.e., 50 and 60 nM, respectively) with high safety index. Molecular docking revealed that the chloro and bromo benzenesulfonamides (15 and 16) may play role in the hydrophobic interaction with Leu477 of the aromatase to mimic steroidal backbone of the natural substrate, androstenedione. QSAR study also revealed that the most potent activity of compounds was governed by van der Waals volume (GATS6v) and mass (Mor03m) descriptors. Finally, the two compounds (15 and 16) were highlighted as promising compounds to be further developed as novel aromatase inhibitors. © 2019 Elsevier Ltd
dc.subjectandrostenedione
dc.subjectaromatase
dc.subjectbenzenesulfonamide derivative
dc.subjectdoxorubicin
dc.subjectletrozole
dc.subjectn,n' (1,3 phenylene)bis(4 chlorobenzenesulfonamide)
dc.subjectn,n' (1,3 phenylene)bis(4 methoxybenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(2 nitrobenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(2,3,5,6 tetramethylbenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(3 aminobenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(3 nitrobenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(4 acetylbenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(4 bromobenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(4 chlorobenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(4 cyanobenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(4 fluorobenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(4 methoxybenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(4 methylbenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(4 nitrobenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(4 trifluoromethylbenzenesulfonamide)
dc.subjectn,n' [1,3 phenylenebis(methylene)]bis(naphthalene 2 sulfonamide)
dc.subjectn,n' [1,4 phenylenebis(methylene)]bis(2,3,5,6 tetramethylbenzenesulfonamide)
dc.subjectn,n' [1,4 phenylenebis(methylene)]bis(4 cyanobenzenesulfonamide)
dc.subjectsulfonamide
dc.subjectunclassified drug
dc.subjectaromatase
dc.subjectaromatase inhibitor
dc.subjectprotein binding
dc.subjectsulfonamide
dc.subjectArticle
dc.subjectbreast cancer
dc.subjectcontrolled study
dc.subjectdrug cytotoxicity
dc.subjectdrug potency
dc.subjectdrug safety
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjectenzyme inhibition
dc.subjecthydrophobicity
dc.subjectIC50
dc.subjectmolecular docking
dc.subjectMRC-5 cell line
dc.subjectquantitative structure activity relation
dc.subjectstructure activity relation
dc.subjectT-47D cell line
dc.subjectbinding site
dc.subjectchemical structure
dc.subjectchemistry
dc.subjecthuman
dc.subjectmetabolism
dc.subjectmolecular library
dc.subjectpharmacology
dc.subjectsynthesis
dc.subjecttumor cell line
dc.subjectAromatase
dc.subjectAromatase Inhibitors
dc.subjectBinding Sites
dc.subjectCell Line, Tumor
dc.subjectHumans
dc.subjectMolecular Docking Simulation
dc.subjectMolecular Structure
dc.subjectProtein Binding
dc.subjectQuantitative Structure-Activity Relationship
dc.subjectSmall Molecule Libraries
dc.subjectSulfonamides
dc.titleSynthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationBioorganic and Medicinal Chemistry. Vol 27, No.19 (2019)
dc.identifier.doi10.1016/j.bmc.2019.08.001
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.